Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Amicus Therapeutics (FOLD)
NASDAQ:FOLD
Amicus (FOLD) Stock Price & Analysis
800 Followers
FOLD Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$7.50 - $13.84
Previous Close$11.11
Volume1.37M
Average Volume (3M)2.47M
Market Cap
$3.16B
Enterprise Value$3.35B
Total Cash (Recent Filing)$267.11M
Total Debt (Recent Filing)$452.01M
Price to Earnings (P/E)-15.7
Beta0.77
Next Earnings
Aug 03, 2023EPS Estimate
-$0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.71
Shares Outstanding284,575,686
10 Day Avg. Volume3,267,463
30 Day Avg. Volume2,469,217
Standard Deviation0.15
R-Squared0.08
Alpha0.00041
Financial Highlights & Ratios
Price to Book (P/B)-34.09
Price to Sales (P/S)36.65
Price to Cash Flow (P/CF)-10.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue9.94
Enterprise Value/Gross Profit11.51
Enterprise Value/Ebitda-19.18
Forecast
1Y Price Target
$14.71Price Target Upside32.40% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
Amicus News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
FOLD FAQ
What was Amicus Therapeutics’s price range in the past 12 months?
Amicus Therapeutics lowest stock price was $7.50 and its highest was $13.84 in the past 12 months.
What is Amicus Therapeutics’s market cap?
Currently, no data Available
When is Amicus Therapeutics’s upcoming earnings report date?
Amicus Therapeutics’s upcoming earnings report date is Aug 03, 2023 which is in 67 days.
How were Amicus Therapeutics’s earnings last quarter?
Amicus Therapeutics released its earnings results on May 10, 2023. The company reported -$0.18 earnings per share for the quarter, missing the consensus estimate of -$0.138 by -$0.042.
Is Amicus Therapeutics overvalued?
According to Wall Street analysts Amicus Therapeutics’s price is currently Undervalued.
Does Amicus Therapeutics pay dividends?
Amicus Therapeutics does not currently pay dividends.
What is Amicus Therapeutics’s EPS estimate?
Amicus Therapeutics’s EPS estimate is -$0.12.
How many shares outstanding does Amicus Therapeutics have?
Amicus Therapeutics has 284,575,680 shares outstanding.
What happened to Amicus Therapeutics’s price movement after its last earnings report?
Amicus Therapeutics reported an EPS of -$0.18 in its last earnings report, missing expectations of -$0.138. Following the earnings report the stock price went down -5.004%.
Which hedge fund is a major shareholder of Amicus Therapeutics?
Among the largest hedge funds holding Amicus Therapeutics’s share is Perceptive Advisors LLC. It holds Amicus Therapeutics’s shares valued at 307M.
---
Amicus Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$14.71 (32.40% Upside)
$14.71 (32.40% Upside)
Blogger Sentiment
Neutral
FOLD Sentiment 50%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 38.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $49.8K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
40.45%
12-Months-Change
Fundamentals
Return on Equity
-119.72%
Trailing 12-Months
Asset Growth
-15.29%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Amicus Therapeutics
Amicus Therapeutics, Inc. engages in the discovery, development, and commercialization of novel treatments for patients living with rare and orphan diseases. Its product include migalastat HCl, which is a small molecule that can be used as a monotherapy and in combination with enzyme replacement therapy for fabry disease. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ.
---
Top 5 ETFs holding FOLD
iShares Biotechnology ETF
$22.26M
Vanguard Health Care ETF
$8.50M
Invesco DWA Healthcare Momentum ETF
$2.16M
iShares NASDAQ US Biotechnology UCITS ETF
$1.58M
Fidelity MSCI Health Care Index ETF
$1.32M
Up to five ETFs with an Outperform Smart Score that hold FOLD. The ETFs are listed according to market value of FOLD within the ETF
---
---